Showing results (201-210 of 2,864) with videos related to

Sort By:
Pageof 287
JACC. Cardiovascular Interventions|May 26, 2009
Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic DissectionRossella Fattori, Thomas T Tsai, Truls Myrmel, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablationDeborah H Kwon, Samir R Kapadia, E Murat Tuzcu, et al.
JACC. Cardiovascular Interventions|May 26, 2009
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trialDavid R Holmes, Paul S Teirstein, Lowell Satler, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter studyKazuhiko Nishigaki, Tsutomu Yamazaki, Akira Kitabatake, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007Valerian L Fernandes, Christopher Nielsen, Sherif F Nagueh, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?Vasilis C Babaliaros, David Liff, Edward P Chen, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized studyBoris Aleil, Laurent Jacquemin, Fabien De Poli, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized studyThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Pageof 287